BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26563517)

  • 1. Increased α1-3 fucosylation of α-1-acid glycoprotein (AGP) in pancreatic cancer.
    Balmaña M; Giménez E; Puerta A; Llop E; Figueras J; Fort E; Sanz-Nebot V; de Bolós C; Rizzi A; Barrabés S; de Frutos M; Peracaula R
    J Proteomics; 2016 Jan; 132():144-54. PubMed ID: 26563517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate data analysis for the detection of human alpha-acid glycoprotein aberrant glycosylation in pancreatic ductal adenocarcinoma.
    Mancera-Arteu M; Giménez E; Balmaña M; Barrabés S; Albiol-Quer M; Fort E; Peracaula R; Sanz-Nebot V
    J Proteomics; 2019 Mar; 195():76-87. PubMed ID: 30641231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of N-glycans from human alfa-acid-glycoprotein using stable isotope labeling and zwitterionic hydrophilic interaction capillary liquid chromatography electrospray mass spectrometry as tool for pancreatic disease diagnosis.
    Giménez E; Balmaña M; Figueras J; Fort E; Bolós C; Sanz-Nebot V; Peracaula R; Rizzi A
    Anal Chim Acta; 2015 Mar; 866():59-68. PubMed ID: 25732693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis.
    Hashimoto S; Asao T; Takahashi J; Yagihashi Y; Nishimura T; Saniabadi AR; Poland DC; van Dijk W; Kuwano H; Kochibe N; Yazawa S
    Cancer; 2004 Dec; 101(12):2825-36. PubMed ID: 15536618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new enzyme immunoassay for the determination of highly sialylated and fucosylated human α
    Yazawa S; Yokobori T; Kaira K; Kuwano H; Asao T
    Clin Chim Acta; 2018 Mar; 478():120-128. PubMed ID: 29274330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation of site-specific glycans of alpha1-acid glycoprotein and alterations in acute and chronic inflammation.
    Higai K; Aoki Y; Azuma Y; Matsumoto K
    Biochim Biophys Acta; 2005 Aug; 1725(1):128-35. PubMed ID: 15863355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoprotein analysis using lectin microcolumns and capillary electrophoresis: Characterization of alpha
    Zhang C; Schumacher KN; Dodds ED; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122855. PubMed ID: 34274643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical evaluation of CZE-UV and CZE-ESI-MS data of intact α-1-acid glycoprotein isoforms for their use as potential biomarkers in bladder cancer.
    Ongay S; Martín-Álvarez PJ; Neusüss C; de Frutos M
    Electrophoresis; 2010 Oct; 31(19):3314-25. PubMed ID: 22216449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylation change of alpha-1-acid glycoprotein as a serum biomarker for hepatocellular carcinoma and cirrhosis.
    Zhang D; Huang J; Luo D; Feng X; Liu Y; Liu Y
    Biomark Med; 2017 May; 11(5):423-430. PubMed ID: 28621608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse lectin ELISA for detecting fucosylated forms of α1-acid glycoprotein associated with hepatocellular carcinoma.
    Åström E; Stål P; Zenlander R; Edenvik P; Alexandersson C; Haglund M; Rydén I; Påhlsson P
    PLoS One; 2017; 12(3):e0173897. PubMed ID: 28296934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct glycoforms of human alpha1-acid glycoprotein have comparable synthesis rates: a [13C]valine-labelling study in healthy humans.
    Poland DC; Kulik W; van Dijk W; Hallemeesch MM; Jakobs C; de Meer K
    Glycoconj J; 2004; 20(2):99-105. PubMed ID: 15001842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific glycosylation of alpha(1)-acid glycoprotein characterises patients with familial Mediterranean fever and obligatory carriers of MEFV.
    Poland DC; Drenth JP; Rabinovitz E; Livneh A; Bijzet J; van het Hof B; van Dijk W
    Ann Rheum Dis; 2001 Aug; 60(8):777-80. PubMed ID: 11454642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (ADLC) plasmas by lectin-capturing and targeted mass spectrometry.
    Ahn YH; Ji ES; Oh NR; Kim YS; Ko JH; Yoo JS
    J Proteomics; 2014 Jun; 106():221-9. PubMed ID: 24780727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do synovial fluid acute phase proteins from patients with rheumatoid arthritis originate from serum?
    Havenaar EC; Dolhain RJ; Turner GA; Goodarzi MT; van Ommen EC; Breedveld FC; van Dijk W
    Glycoconj J; 1997 Jun; 14(4):457-65. PubMed ID: 9249143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a novel lectin-antibody ELISA system to determine core-fucosylated haptoglobin.
    Shimomura M; Nakayama K; Azuma K; Terao N; Nishino K; Takamatsu S; Nakano M; Takahashi S; Kobayashi Y; Murata K; Kamada Y; Miyoshi E
    Clin Chim Acta; 2015 Jun; 446():30-6. PubMed ID: 25861849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucosylation of serum alpha1-acid glycoprotein in rheumatoid arthritis patients treated with infliximab.
    Olewicz-Gawlik A; Korczowska-Łacka I; Łacki JK; Klama K; Hrycaj P
    Clin Rheumatol; 2007 Oct; 26(10):1679-84. PubMed ID: 17310270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lectin immunosensor technique for determination of alpha(1)-acid glycoprotein fucosylation.
    Liljeblad M; Rydén I; Ohlson S; Lundblad A; Påhlsson P
    Anal Biochem; 2001 Jan; 288(2):216-24. PubMed ID: 11152593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effect of the immunopurification-based procedures on the CZE-UV and CZE-ESI-TOF-MS determination of isoforms of intact alpha-1-acid glycoprotein from human serum.
    Ongay S; Neusübeta C; Vaas S; Díez-Masa JC; de Frutos M
    Electrophoresis; 2010 Jun; 31(11):1796-804. PubMed ID: 20446289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum N-Glycome analysis reveals pancreatic cancer disease signatures.
    Vreeker GCM; Hanna-Sawires RG; Mohammed Y; Bladergroen MR; Nicolardi S; Dotz V; Nouta J; Bonsing BA; Mesker WE; van der Burgt YEM; Wuhrer M; Tollenaar RAEM
    Cancer Med; 2020 Nov; 9(22):8519-8529. PubMed ID: 32898301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
    Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
    Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.